PREMIER VALUE POVIDONE IODINE- povidone iodine 10% liquid 
Chain Drug Consortium

----------

Premier Value Povidone Iodine

Drug Facts

Active Ingredient

Povidone-Iodine 10%

(Equivalent to 1% titrable iodine)

Purpose

Antiseptic

Use

First aid antiseptic to prevent infection in minor cuts and burns.

Warnings

For External Use Only

Ask a doctor before use if you have

Stop use and consult a doctor if

When using this product do not

Keep out of reach of children.

In case of accidental ingestion, seek professional assistance or contact a Poison Control Center immediately.

Directions

Clean the affected area. Apply a small amount on the area 1 to 3 times daily. May be covered with sterile bandage. If badaged, let it dry first.

Other information

store at room temperature, 20-25C (68-77F)

Inactive Ingredients

Citric Acid, Disodium Phosphate, Glycerin, nonoxynol-9. Sodium Hydroxide and Purified Water.

Label

PVPov.jpgPV Povidone

PREMIER VALUE POVIDONE IODINE 
povidone iodine 10% liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68016-415
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
POVIDONE-IODINE (UNII: 85H0HZU99M) (IODINE - UNII:9679TC07X4) IODINE100 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
GLYCERIN (UNII: PDC6A3C0OX)  
NONOXYNOL-9 (UNII: 48Q180SH9T)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:68016-415-00237 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product10/30/2017
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00301/01/2008
Labeler - Chain Drug Consortium (101668460)
Registrant - Pharma Nobis, LLC (118564114)
Establishment
NameAddressID/FEIBusiness Operations
Pharma Nobis, LLC118564114manufacture(68016-415) , analysis(68016-415) , pack(68016-415) , label(68016-415)

Revised: 12/2023
Document Id: 0cf4f274-9fc2-f48e-e063-6394a90a9d3f
Set id: 5cc9d782-5f7e-27d9-e053-2991aa0a2428
Version: 5
Effective Time: 20231220
 
Chain Drug Consortium